CARB-X
CARB-X Awards $3M to AstraDx for Neonatal Sepsis Test Development
The diagnostics startup is developing a testing platform that uses digital imaging and signal processing for pathogen identification and susceptibility determination.
Rhode Island Hospital Wins $1M From CARB-X for Molecular Pneumonia Blood Test
The funding supports proof-of-concept studies of a direct-from-blood PCR test informed by RNA sequencing to detect pneumonia-causing bacteria.
CARB-X Grants Melio $3.5M for Neonatal Sepsis Test, Visby Wins Additional $3.9M
The Melio funding will support a diagnostic test using acoustic sample prep and melt curve detection.
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
The company plans to use the funding to demonstrate proof of concept and feasibility for a rapid test to detect chlamydia and gonorrhea.